Penile Cancer
An uncommon cancer arising on the penis that is highly treatable when caught early, with specialist care focused on both controlling the cancer and preserving function where possible.
- Organ-preserving surgical options
- Specialist urologic oncology review
- Lymph node staging expertise
- Most Common Type
- Squamous Cell Carcinoma
- Key Risk Factor
- HPV Infection
- Critical Factor
- Lymph Node Status
- Advanced Therapies
- Immunotherapy, Targeted Agents
Condition Overview
Penile cancer is an uncommon cancer that develops on the skin or tissues of the penis, most often as squamous cell carcinoma. It typically begins on the glans (head) or foreskin and may present as a visible lesion, sore, or change in skin texture.
While rare in many parts of the world, penile cancer is more common in regions with lower rates of circumcision and higher rates of human papillomavirus (HPV) infection. Early detection significantly improves the chances of organ-preserving treatment.
Because the disease can spread to the lymph nodes in the groin, accurate assessment of lymph node involvement is one of the most important factors in both staging and treatment planning.
Types and Subtypes
Penile cancers are classified by histology, which can influence both behavior and treatment approach.
Symptoms and Signs
Symptoms of penile cancer often involve visible changes to the skin of the penis, which can sometimes be mistaken for infection or a benign skin condition, leading to delayed diagnosis.
Causes and Risk Factors
Several factors are known to increase the risk of developing penile cancer, many of which relate to chronic irritation, infection, or hygiene factors.
Diagnosis and Investigations
Diagnosis of penile cancer involves physical examination, biopsy of the lesion, and assessment of regional lymph nodes.
Staging and Risk Groups
Penile cancer is staged using the TNM system, with particular attention to depth of invasion and lymph node involvement.
Standard Treatment
Treatment of penile cancer balances cancer control with preservation of urinary and sexual function whenever feasible.
Advanced & Emerging Therapies
For advanced or recurrent penile cancer, newer systemic therapies are being studied and increasingly used alongside traditional chemotherapy.
Immunotherapy
Checkpoint Inhibitors
Being studied and used in advanced penile cancer, with particular interest in tumors with high PD-L1 expression.
Targeted Therapy
EGFR-Targeted Agents
Penile squamous cell carcinomas frequently express EGFR, making this an area of investigational targeted treatment.
Radiation
Brachytherapy
An organ-preserving radiation technique used for select early-stage tumors as an alternative to surgery.
Precision Medicine
HPV-Targeted Approaches
Research is exploring whether HPV status can guide more personalized treatment strategies in penile cancer.
Biomarkers & Precision Medicine
Pathologic and molecular features help refine prognosis and guide management decisions in penile cancer.
When to Seek a Second Opinion
Because penile cancer is uncommon, treatment decisions benefit from input from centers with specific experience in this disease.
Clinical Trials & Research
Prognosis & Outcomes
Penile cancer detected early and confined to the penis generally has a favorable outlook, particularly when lymph nodes are not involved. Lymph node status is one of the strongest determinants of long-term outcome.
Supportive Care
Supportive care in penile cancer addresses both the physical and emotional impact of diagnosis and treatment, particularly given the sensitive nature of the affected area.
How CancerFax Helps You Explore Treatment Options
CancerFax can help coordinate medical report review, second opinions, and access to specialist urologic oncology centers experienced in penile cancer.
Get a free case reviewFrequently Asked Questions
Early signs often include a lump, sore, or skin change on the penis that does not heal, sometimes accompanied by discharge or bleeding. Because these signs can resemble other conditions, prompt evaluation by a clinician is important.
A significant proportion of penile cancers are associated with human papillomavirus (HPV) infection, though not all cases are HPV-related. Other factors, such as chronic skin conditions and lack of circumcision, also contribute to risk.
Not necessarily. Many early-stage penile cancers can be treated with organ-preserving approaches such as local excision or laser therapy. More extensive surgery is generally reserved for larger or deeply invasive tumors.
Penile cancer can spread to the lymph nodes in the groin, and whether this has happened is one of the most important factors influencing both treatment and prognosis.
It is a procedure that identifies and removes the first lymph nodes that drain the area of the tumor, helping determine whether cancer has spread without removing all groin lymph nodes.
Yes, recurrence is possible, which is why regular follow-up examinations are important after treatment, particularly in the first few years.
Circumcision is associated with a lower risk of penile cancer, but it does not eliminate risk entirely. Other risk factors, including HPV infection and smoking, also play a role.
Immunotherapy is being studied for advanced or recurrent penile cancer and may be considered in select cases, often as part of a clinical trial or specialist-guided treatment plan.
Treatment can affect sexual function depending on the extent of surgery required. Psychosexual counseling and, in some cases, reconstructive options can help address these concerns.
Yes. CancerFax can help you organize and share your medical reports for specialist urologic oncology review, coordinate a second opinion, explore access to organ-preserving surgical options and advanced therapies, and support cross-border coordination with international treatment centers if that is part of your care plan.
Get Expert Guidance on Your Penile Cancer Diagnosis
Share your medical reports with our team to explore treatment options, second opinions, and organ-preserving approaches.